Agents for inhibiting the production of IL-1 beta and the release of TNF alpha

The pharmaceutical use of 1-cinnamoyl-2-pyrrolidinone derivatives having the activities to inhibit the production of IL-1 beta and the release of TNF alpha . Those derivatives are useful in the treatment or prophylaxis of the diseases such as chronic rheumatism and sepsis.\!

Saved in:
Bibliographic Details
Main Authors MOMOSE; KENICHI, SAITO; YUKIO, KATSUYAMA; KOICHI, HATANAKA; SHIGEO, ARIGA; MASATO
Format Patent
LanguageEnglish
Published 19.05.1998
Edition6
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The pharmaceutical use of 1-cinnamoyl-2-pyrrolidinone derivatives having the activities to inhibit the production of IL-1 beta and the release of TNF alpha . Those derivatives are useful in the treatment or prophylaxis of the diseases such as chronic rheumatism and sepsis.\!
Bibliography:Application Number: US19950577338